Keyword: Sorrento Therapeutics

Sorrento drops 39% before Easter after shares offering

San Diego biotech Sorrento, which spent much of the last 12 months warring with its minority stakeholder Wildcat, won’t be finding many golden eggs this weekend after being the biggest biotech stock loser ahead of today’s market close.